Hainan Shuangcheng Pharmaceuticals Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 269.441 million compared to CNY 346.648 million a year ago. Operating loss was CNY 78.754 million compared to operating Income of CNY 7.887 million a year ago. Net loss was CNY 53.329 million compared to net income of CNY 24.656 million a year ago. Basic loss per share from continuing operations was CNY 0.13 compared to basic earnings per share from continuing operations of CNY 0.06 a year ago.